| Long name: |
Recombinant Dog Apolipoprotein C-I (APOC1 ) |
| Alternative names: |
Apo-CIB', ApoC-IB', Apolipoprotein C-I, Apolipoprotein C1Cleaved into the following chain:Truncated apolipoprotein C-I, apolipoprotein C-I, apolipoprotein C1, apolipoprotein C-I |
| Gene name: |
APOC1 |
| Other gene names: |
APOC1, APOC1B, Apo-CIB, Apo-CIB, Apo-CIB', ApoC-IB, ApoC-IB, ApoC-IB', APOC1 |
| General description: |
All of our recombinant proteins are manufactured in strictly controlled facilities and by using a well established technology which guarantees full batch-to-bact consistency and experiment reproducibility, The protein can be with or without a His-Tag or other tag in accordance to customer's request, coli, Apolipoprotein C-I (APOC1 ) is a recombinant protein expressed in E |
| Product category: |
Recombinant Proteins |
| Expression system: |
coli, E |
| Available also expressed in:: |
Baculovirus , Mammalian Cell, Yeast , E Coli |
| Purity: |
Greater than 90% (determined by SDS-PAGE) |
| Form: |
Lyophilized protein |
| Storage: |
Avoid cycles of freezing and thawing as they might denaturate the polypeptide chains, For extended periods of time it is recommended to keep the protein frozen at -40 or -80 degrees Celsius, This protein can be stored at -20 degrees Celsius |
| Applications: |
IFA, RIA, Western Blot, etc, This protein can be used as a positive control for applications such as ELISA |
| Properties: |
MBS Recombinant Proteins produces ELISA test kits and polyclonal antibodies, Canine or Canis Lupus is mostly Beagle used for drug research |
| Gene target: |
Apolipoprotein C-I (APOC1 |
| Short name: |
Apolipoprotein C-I (APOC1 ) |
| Species: |
Dogs, Dog |
| Alternative name: |
canine Apolipoprotein C-I (apolipoprotein C-I ) |
| Alternative to gene target: |
APOC1 and IDBG-56839 and ENSG00000130208 and 341, Apoc1 and IDBG-152061 and ENSMUSG00000040564 and 11812, Extracellular, phosphatidylcholine-sterol O-acyltransferase activator activity, this GO :0004859 and phospholipase inhibitor activity and molecular function this GO :0005504 and fatty acid binding and molecular function this GO :0005576 and extracellular region and cellular component this GO :0005783 and endoplasmic reticulum and cellular component this GO :0006629 and lipid metabolic process and biological process this GO :0006641 and triglyceride metabolic process and biological process this GO :0008203 and cholesterol metabolic process and biological process this GO :0010873 and positive regulation of cholesterol esterification and biological process this GO :0010900 and negative regulation of phosphatidylcholine catabolic process and biological process this GO :0010916 and negative regulation of very-low-density lipoprotein particle clearance and biological process this GO :0031210 and phosphatidylcholine binding and molecular function this GO :0032374 and regulation of cholesterol transport and biological process this GO :0032375 and negative regulation of cholesterol transport and biological process this GO :0033344 and cholesterol efflux and biological process this GO :0033700 and phospholipid efflux and biological process this GO :0034361 and very-low-density lipoprotein particle and cellular component this GO :0034364 and high-density lipoprotein particle and cellular component this GO :0034369 and plasma lipoprotein particle remodeling and biological process this GO :0034375 and high-density lipoprotein particle remodeling and biological process this GO :0034379 and very-low-density lipoprotein particle assembly and biological process this GO :0034382 and chylomicron remnant clearance and biological process this GO :0034447 and very-low-density lipoprotein particle clearance and biological process this GO :0042157 and lipoprotein metabolic process and biological process this GO :0042627 and chylomicron and cellular component this GO :0043085 and positive regulation of catalytic activity and biological process this GO :0045717 and negative regulation of fatty acid biosynthetic process and biological process this GO :0045833 and negative regulation of lipid metabolic process and biological process this GO :0048261 and negative regulation of receptor-mediated endocytosis and biological process this GO :0050995 and negative regulation of lipid catabolic process and biological process this GO :0051005 and negative regulation of lipoprotein lipase activity and biological process this GO :0055102 and lipase inhibitor activity and molecular function this GO :0060228 and phosphatidylcholine-sterol O-acyltransferase activator activity and molecular function this GO :0070062 and extracellular vesicular exosome and cellular component, this GO :0004859 : phospholipase inhibitor activity, this GO :0004859 : phospholipase inhibitor activity and also this GO :0005504 : fatty acid binding and also this GO :0031210 : phosphatidylcholine binding and also this GO :0055102 : lipase inhibitor activity and also this GO :0060228 : phosphatidylcholine-sterol O-acyltransferase activator activity, this GO :0005504 : fatty acid binding, this GO :0031210 : phosphatidylcholine binding, this GO :0055102 : lipase inhibitor activity, this GO :0060228 : phosphatidylcholine-sterol O-acyltransferase activator activity, apolipoprotein C-I |
| Identity: |
607 |
| Gene: |
APOC1 |
More about : APOC1 |
| Long gene name: |
apolipoprotein C1 |
| Synonyms gene name: |
apolipoprotein C-I |
| Locus: |
19q13, 32 |
| Discovery year: |
2001-06-22 |
| GenBank acession: |
X00570 |
| Entrez gene record: |
341 |
| Classification: |
Apolipoproteins |
| Havana BLAST/BLAT: |
OTTHUMG00000180844 |